spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

Cell Therapy Manufacturing & Gene Therapy Congress

Cell Therapy Manufacturing & Gene Therapy Congress

4-6 December 2018
RAI, Amsterdam

Bringing together 300+ leaders and key influencers from pharma and biotech companies on 4 - 6 December 2018 in Amsterdam, Cell Therapy Manufacturing & Gene Therapy will provide you with the latest advice for transforming innovative research to prosperous cell & gene therapy manufacturing.

Gain regulatory approval. Maximise ROI. Ensure a stringent vein-to-vein supply chain.

Discover everything you need in one place. Move between 4 streams jam packed with topical talks and industry case studies. PLUS it’s the perfect opportunity to meet with colleagues for an unrivalled on-site experience.

Contact details of organisers:

Registrations: LS.Registrations@knect365.com

Agenda/Speaker Inquiries: Sarah Lintern - Sarah.Lintern@knect365.com

Marketing, Media and Website Inquiries: Shahana Chowdhury - Shahana.Chowdhury@knect365.com

Exhibition & Sponsorship Inquiries: Luke Pickering – Luke.Pickering@knect365.com
phone +44 (0)20 7017 7200
email LS.Registrations@Knect365.com
web https://bit.ly/2NaX6dm
email RAI, Amsterdam
 
Print this page
Send to a friend
   
spacer
Industry Events

PDA Europe Annual Meeting 2019

24 June 2019, Hilton Amsterdam

Featuring updates from international regulatory agencies as well as industry, this promises to become another highlight in the 2019 event calendar and is a meeting not to be missed!
More info >>

White Papers

Systems Engineering for Complex Portable Medical Device Development

Phillips-Medisize

As the demand for complex, portable medical devices continues to grow, reducing risk and increasing efficiency during the development of these products should be paramount. Taking a systems-engineering (SE) approach to development provides a holistic, organized, and deliberate method for identifying as well as reducing both patient and business risks early in the process. Furthermore, it facilitates efficient progression throughout the entire product development life cycle.
More info >>


News and Press Releases

MedPharm announce expansion of partnership with Palvella Therapeutics in developing a new treatment for the debilitating rare disease, pachyonychia congenita

MedPharm Ltd have announced the expansion of their partnership with Palvella Therapeutics, Inc., a Philadelphia-based biopharmaceutical company focused on developing and commercialising therapies for debilitating, rare genetic diseases. To date, MedPharm has employed its world-renowned specialist formulation expertise to support Palvella’s development of a novel, high-strength rapamycin topical formulation for application to the skin (PTX 022) as a disease-modifying treatment for pachyonychia congenita (PC). Most recently, MedPharm has made arrangements to manufacture the clinical (IMP) batches for use in Palvella’s upcoming Phase 2/3 clinical study.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement